Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

Tumor volume measurements. by Hedieh Zargaran (21410233)

IL-10 levels in tumor lysates post-treatment. by Hedieh Zargaran (21410233)

Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

“…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

NCOA4 is downregulated in human CCA tissues and is correlated with poor prognosis. by Wenlong Shen (9313937)

Subjects:

Experimental groups. by Nida Saleem (17194610)

Subjects:

Association of BMI with primary and secondary outcomes after adjusting for age, sex, index of multiple deprivation (for the United Kingdom data), primary surgical indication and Am... by Epaminondas Markos Valsamis (8194083)

Subjects:

BMI distribution of study population using World Health Organisation (WHO) categories. by Epaminondas Markos Valsamis (8194083)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Primer sequences for RT-qPCR. by Wenlong Shen (9313937)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Low NCOA4 expression promotes the migration and invasion of CCA cells in vitro. by Wenlong Shen (9313937)

Subjects:

Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

Subjects:

Alterations in hematological parameters induced by dimethoate after 90 days. by Nida Saleem (17194610)

Subjects:

Association of BMI with primary and secondary outcomes after adjusting for age, sex, index of multiple deprivation (for the United Kingdom data), primary surgical indication and Am... by Epaminondas Markos Valsamis (8194083)

Subjects: